' + activeFrame.title + '
');
$(".fotorama-caption").addClass("add_caption");
$(".fotorama-caption").removeClass("remove_caption");
} else {
// alert("hide div");
$(".fotorama-caption").addClass("remove_caption");
$(".fotorama-caption").removeClass("add_caption");
}
})
.fotorama();
Impact of vaccine challenges: Addressing the gaps
Sunday, June 27, 2021
The
consequences of a lack of equitable access to vaccines continue to be evident in Jamaica and in many other developing countries. The shortage of vaccines in developing countries, due partially to hoarding by developed countries, has shaped public perception in the national space and led to fears that many people will not have access to vaccines in general and second doses in particular.
Approximately 9 per cent — more than 220,000 people — of the Jamaican population has received at least one dose of the AstraZeneca vaccine. Over 50,000 are fully vaccinated. Vaccination rates are significantly higher than this in high-income countries, when compared to middle- and low-income countries, revealing the global disparities in the distribution of, and access to, vaccines. There are countries such as the UK that have vaccinated up to 80 per cent of their adult population, while only 0.9 per cent of people in low-income countries have received at least one dose. Other countries in the north, such as the US, have administered at least one dose to more than half of their population.